Fingerprint
Dive into the research topics of 'Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors
Kiyosumi Shibata, F. Kikkawa, M. Mika, Y. Suzuki, H. Kajiyama, K. Ino, S. Mizutani
Research output: Contribution to journal › Article › peer-review
44
Citations
(Scopus)